A first-in-class CDK4 inhibitor demonstrates in vitro,...

  • Main
  • 2020 / 9
  • A first-in-class CDK4 inhibitor demonstrates in vitro,...
Gynecologic Oncology 2020 / 9

A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer

Bantie, Laychiluh, Tadesse, Solomon, Likisa, Jimma, Yu, Mingfeng, Noll, Benjamin, Heinemann, Gary, Lokman, Noor A., Ricciardelli, Carmela, Oehler, Martin K., Beck, Andrew, Pradhan, Rupal, Milne, Rober
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2020.09.012
Date:
September, 2020
File:
PDF, 5.07 MB
2020
Conversion to is in progress
Conversion to is failed